Help us: Donate
Follow us on:
×

Category: Interviews

Eric Verdin
Six years ago, Dr. Eric Verdin, already a highly acclaimed veteran geroscientist, was catapulted to the forefront of the field when he agreed to lead the Buck Institute for Research on Aging (or simply “the Buck”), a renowned research institution based in Novato, CA. We talked to Dr. Verdin about his vision for the Buck...
Aubrey de Grey LEVF
Dr. Aubrey de Grey is a legend in the longevity field who has been steadfastly promoting the idea of life extension since well before it became mainstream. While with SENS Research Foundation, de Grey made significant contributions to geroscience, and at Longevity Summit Dublin last year, he announced the creation of his new brainchild, Longevity...
Emma Teeling Interview Image
Emma Teeling is a professor at University College of Dublin, and her research focuses on bats. In this interview, Emma explains why many bats, despite having tiny body sizes and leading very metabolically demanding lifestyles, are so amazingly long-lived. Will we ever be able to learn these animals' secrets of beating the odds? Emma is...
H.E. Justin Sun Interview
In October, H.E. Justin Sun, founder of the blockchain DAO ecosystem TRON, announced his donation to The Longevity Prize, a series of prizes designed to boost longevity science. In so doing, he has joined the ranks of other crypto entrepreneurs interested in the evolving field. In this interview, he tells Lifespan.io more about why he...
Kaeberlein
Dr. Matt Kaeberlein is a heavy hitter in the longevity field. While his name has become associated with the Dog Aging Project that he started a few years ago, his research interests span much wider. Besides an update on the Dog Aging Project, which is still recruiting dogs, we wanted to talk with Dr. Kaeberlein...
Lou Hawthorne
Lou Hawthorne is the founder and CEO of NaNotics, a biotech company that creates nanoparticles that can soak up harmful molecules in circulation. This paradigm-shifting technology can be used to fight cancer as well as various inflammatory disorders, such as sepsis, which kills more people than cancer does. Other potential targets, familiar to everyone in...